153 related articles for article (PubMed ID: 9401542)
1. Effects of growth hormone treatment on growth and body composition in Prader-Willi syndrome: a preliminary report. The Swedish National Growth Hormone Advisory Group.
Lindgren AC; Hagenäs L; Müller J; Blichfeldt S; Rosenborg M; Brismar T; Ritzén EM
Acta Paediatr Suppl; 1997 Nov; 423():60-2. PubMed ID: 9401542
[TBL] [Abstract][Full Text] [Related]
2. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
3. One-year results of growth hormone treatment of short stature in Prader-Willi syndrome.
Hauffa BP
Acta Paediatr Suppl; 1997 Nov; 423():63-5. PubMed ID: 9440907
[TBL] [Abstract][Full Text] [Related]
4. Physical effects of growth hormone treatment in children with Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
Acta Paediatr Suppl; 1999 Dec; 88(433):112-4. PubMed ID: 10626559
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
6. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
7. Effect of 6 months of growth hormone treatment in young children with Prader-Willi syndrome.
Eiholzer U; Weber R; Stutz K; Steinert H
Acta Paediatr Suppl; 1997 Nov; 423():66-8. PubMed ID: 9401543
[TBL] [Abstract][Full Text] [Related]
8. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
Lindgren AC; Lindberg A
Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome.
Böhm B; Ritzén EM; Lindgren AC
Acta Paediatr; 2015 Jan; 104(1):59-67. PubMed ID: 25263744
[TBL] [Abstract][Full Text] [Related]
12. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
13. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Hagenäs L; Ritzén EM
Horm Res; 1999; 51(4):157-61. PubMed ID: 10474015
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).
Craig ME; Cowell CT; Larsson P; Zipf WB; Reiter EO; Albertsson Wikland K; Ranke MB; Price DA;
Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957
[TBL] [Abstract][Full Text] [Related]
16. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects.
Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Schroor EJ; Van Alfen AA; Van Leeuwen M; Van Pinxteren-Nagler E; Van Wieringen H; Vreuls RC; Zwaveling-Soonawala N; de Ridder MA; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Oct; 98(10):4013-22. PubMed ID: 24001750
[TBL] [Abstract][Full Text] [Related]
17. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children.
Tauber M; Barbeau C; Jouret B; Pienkowski C; Malzac P; Moncla A; Rochiccioli P
Horm Res; 2000; 53(6):279-87. PubMed ID: 11146368
[TBL] [Abstract][Full Text] [Related]
18. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
[TBL] [Abstract][Full Text] [Related]
19. Benefit of early commencement of growth hormone therapy in children with Prader-Willi syndrome.
Nyunt O; Harris M; Hughes I; Huynh T; Davies PS; Cotterill AM
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1151-8. PubMed ID: 20333875
[TBL] [Abstract][Full Text] [Related]
20. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.
Haqq AM; Stadler DD; Jackson RH; Rosenfeld RG; Purnell JQ; LaFranchi SH
J Clin Endocrinol Metab; 2003 May; 88(5):2206-12. PubMed ID: 12727976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
